Smarcb1-deficient Tumors
📧 Sign up to get email alerts when something new happens for Smarcb1-deficient Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-03-04Clinical Trial Update: FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors [Phase 1]
This update reports that the Phase 1 trial of FHD-609 for advanced synovial sarcoma and SMARCB1-deficient tumors has been terminated.